Back to Walleye Capital LLC Walleye Capital LLC

KNSAKNSA

Showing 0 of 8 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in KINIKSA PHARMACEUTICALS-A

No. Walleye Capital exited its KNSA (Kiniksa Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 327,332 shares worth $5.7M. Walleye Capital first reported KNSA in Q4 2021 and held it in 6 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used